$22.29
1.78% yesterday
NYSE, Jan 06, 10:00 pm CET
ISIN
US58502B1061
Symbol
MD

MEDNAX, Inc. Stock price

$22.29
+0.72 3.34% 1M
+8.84 65.72% 6M
+0.90 4.21% YTD
+9.49 74.14% 1Y
+7.31 48.80% 3Y
-1.48 6.23% 5Y
-46.96 67.81% 10Y
+0.35 1.60% 20Y
NYSE, Closing price Tue, Jan 06 2026
+0.39 1.78%

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$2.0b
Net debt
$139.4m
Cash
$463.1m
Shares outstanding
85.8m
Valuation (TTM | estimate)
P/E
11.5 | 10.2
P/S
1.0 | 1.0
EV/Sales
1.1 | 1.0
EV/FCF
7.4
P/B
2.1
Financial Health
Equity Ratio
35.5%
Return on Equity
-13.0%
ROCE
13.0%
ROIC
11.2%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$1.9b | $2.0b
EBITDA
$257.6m | $289.5m
EBIT
$234.5m | $253.8m
Net Income
$162.2m | $184.3m
Free Cash Flow
$273.4m
Growth (TTM | estimate)
Revenue
-4.2% | -2.4%
EBITDA
29.4% | 34.1%
EBIT
42.5% | 38.2%
Net Income
163.9% | 286.0%
Free Cash Flow
137.3%
Margin (TTM | estimate)
Gross
-
EBITDA
13.4% | 14.7%
EBIT
12.2%
Net
8.4% | 9.4%
Free Cash Flow
14.2%
More
EPS
$1.9
FCF per Share
$3.2
Short interest
5.5%
Employees
4k
Rev per Employee
$490.0k
Show more

Is MEDNAX, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.

MEDNAX, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a MEDNAX, Inc. forecast:

9x Buy
60%
6x Hold
40%

Analyst Opinions

15 Analysts have issued a MEDNAX, Inc. forecast:

Buy
60%
Hold
40%

Financial data from MEDNAX, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,922 1,922
4% 4%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 1,581 1,581
6% 6%
82%
- Research and Development Expense - -
-
-
258 258
29% 29%
13%
- Depreciation and Amortization 23 23
33% 33%
1%
EBIT (Operating Income) EBIT 235 235
42% 42%
12%
Net Profit 162 162
164% 164%
8%

In millions USD.

Don't miss a Thing! We will send you all news about MEDNAX, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MEDNAX, Inc. Stock News

Neutral
Seeking Alpha
2 months ago
Pediatrix Medical Group, Inc. ( MD ) Q3 2025 Earnings Call November 3, 2025 9:00 AM EST Company Participants Mary Ann Moore - Chief Administrative Officer, Executive VP, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Kieran Ryan - Deutsche Bank AG, ...
Neutral
Business Wire
2 months ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results; Raises Full Year 2025 Adjusted EBITDA Outlook Range.
Neutral
Business Wire
3 months ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025.
More MEDNAX, Inc. News

Company Profile

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Head office United States
CEO Mark Ordan
Employees 4,120
Founded 1979
Website www.pediatrix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today